Lapchak P A, Miller P J, Jiao S
AMGEN Inc., Department of Neuroscience, Thousand Oaks, CA 91320-1789, U.S.A.
Neuroscience. 1997 Apr;77(3):745-52. doi: 10.1016/s0306-4522(96)00492-7.
Glial cell line-derived neurotrophic factor has been shown to affect dopaminergic and cholinergic neuron markers and functions in young rats. However, it is not known if the response to exogenous glial cell line-derived neurotrophic factor is augmented during normal aging. Thus, the effects of chronic intraventricular infusions of glial cell line-derived neurotrophic factor were determined in young adult (three-months-old) and aged (24-months-old) Fischer 344 (F344) male rats. The effects of glial cell line-derived neurotrophic factor were compared to the effects of the neurotrophin nerve growth factor. Growth factors were administered at a dose of 10 mg/day for 14 days. Locomotor activity and weight changes were also examined in all rats. Aged F344 rats showed significantly reduced (by 75-80%) locomotor activity compared to young rats. In glial cell line-derived neurotrophic factor-treated aged and young rats there was significantly increased (242% and 149%, respectively) locomotor activity measured at seven days. There was also a significant increase in locomotor activity measured 14 days after the start of infusion. Both glial cell line-derived neurotrophic factor and nerve growth factor reduced weight gain by 10% in young and old F344 rats. Two weeks following the start of nerve growth factor or glial cell line-derived neurotrophic factor administration the brains were used for neurochemical analyses. Glial cell line-derived neurotrophic factor significantly increased tyrosine hydroxylase activity in the substantia nigra and striatum of aged rats and in the substantia nigra of young rats. Nerve growth factor treatment did not significantly affect tyrosine hydroxylase activity. However, glial cell line-derived neurotrophic factor and nerve growth factor increased choline acetyltransferase activity in the septum, hippocampus, striatum and cortex of aged rats and in the hippocampus and striatum of young rats to a comparable degree. These findings indicate that specific dopaminergic and cholinergic neuron populations remain responsive to glial cell line-derived neurotrophic factor during the life span of the rat and may be involved in maintaining phenotypic expression within multiple neuronal populations. Additionally, the glial cell line-derived neurotrophic factor-induced up-regulation of brain neurotransmitter systems may be responsible for increased locomotor activity in F344 rats.
胶质细胞系源性神经营养因子已被证明会影响幼鼠的多巴胺能和胆碱能神经元标志物及功能。然而,尚不清楚在正常衰老过程中对外源性胶质细胞系源性神经营养因子的反应是否会增强。因此,在年轻成年(三个月大)和老年(24个月大)的Fischer 344(F344)雄性大鼠中,确定了慢性脑室内注射胶质细胞系源性神经营养因子的效果。将胶质细胞系源性神经营养因子的效果与神经营养因子神经生长因子的效果进行了比较。以10毫克/天的剂量给药生长因子,持续14天。还对所有大鼠的运动活性和体重变化进行了检查。与年轻大鼠相比,老年F344大鼠的运动活性显著降低(降低75 - 80%)。在接受胶质细胞系源性神经营养因子治疗的老年和年轻大鼠中,在第7天测量的运动活性显著增加(分别增加242%和149%)。在开始输注14天后测量的运动活性也有显著增加。胶质细胞系源性神经营养因子和神经生长因子均使年轻和老年F344大鼠的体重增加减少10%。在开始给予神经生长因子或胶质细胞系源性神经营养因子两周后,取脑进行神经化学分析。胶质细胞系源性神经营养因子显著增加了老年大鼠黑质和纹状体以及年轻大鼠黑质中的酪氨酸羟化酶活性。神经生长因子治疗对酪氨酸羟化酶活性没有显著影响。然而,胶质细胞系源性神经营养因子和神经生长因子使老年大鼠的隔区、海马、纹状体和皮质以及年轻大鼠的海马和纹状体中的胆碱乙酰转移酶活性增加到相当程度。这些发现表明,在大鼠的寿命期间,特定的多巴胺能和胆碱能神经元群体对胶质细胞系源性神经营养因子仍有反应,并且可能参与维持多个神经元群体内的表型表达。此外,胶质细胞系源性神经营养因子诱导的脑内神经递质系统上调可能是F344大鼠运动活性增加的原因。